After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$498.22K

Rothblatt Martine A Chairperson & CEO

Transaction date Jun 10, 2026
Public filing date Jun 11, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$544.1 Jun 10, 2026
First close after public filing
$545.96 Jun 12, 2026
30-day return after filing
-1.9% Through Jul 13, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
914 shares @ $545.1
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001106578-26-000074
Filing cohort

Transactions in this filing

Showing 15 of 19
Trades
19
Issuers
1
Estimated value
$6.57M
Buys / sales
0 / 17
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jun 10, 2026 $1.39M
United Therapeutics Corp UTHR Sale Jun 10, 2026 $323.47K
United Therapeutics Corp UTHR Sale Jun 10, 2026 $432.11K
United Therapeutics Corp UTHR Sale Jun 10, 2026 $461.07K
United Therapeutics Corp UTHR Sale Jun 10, 2026 $627.9K
United Therapeutics Corp UTHR Sale Jun 10, 2026 $447.65K
United Therapeutics Corp UTHR Sale Jun 10, 2026 $471.93K
United Therapeutics Corp UTHR Current Sale Jun 10, 2026 $498.22K
United Therapeutics Corp UTHR Sale Jun 10, 2026 $117.42K
United Therapeutics Corp UTHR Sale Jun 10, 2026 $210.63K
United Therapeutics Corp UTHR Sale Jun 10, 2026 $134.96K
United Therapeutics Corp UTHR Sale Jun 10, 2026 $279.25K
United Therapeutics Corp UTHR Sale Jun 10, 2026 $85.89K
United Therapeutics Corp UTHR Sale Jun 10, 2026 $49.64K
United Therapeutics Corp UTHR Sale Jun 10, 2026 $324.99K